Lucaser, Eulalia A.
HRN: 24-68-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2024
CEFTRIAXONE 1G (VIAL)
03/11/2024
03/17/2024
IV
2gm
Q24
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes